Redmile Group, LLC Axonics, Inc. Transaction History

Redmile Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $31.3 Million - $38.2 Million	-741,129 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $15.9 Million - $23 Million	-450,971 Reduced 37.83%	741,129 $37.8 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $7.22 Million - $12.6 Million	-315,300 Reduced 20.92%	1,192,100 $41.9 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $404,424 - $928,157	-24,600 Reduced 1.61%	1,507,400 $38.3 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $14.1 Million - $20.9 Million	722,300 Added 89.21%	1,532,000 $42.5 Million
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $102,296 - $161,158	-3,800 Reduced 0.47%	809,700 $21.8 Million
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $3.98 Million - $8.8 Million	214,900 Added 35.9%	813,500 $33.3 Million
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $18,648 - $34,090	-1,400 Reduced 0.23%	598,600 $14.3 Million
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $7.92 Million - $9.86 Million	600,000 New	600,000 $9.07 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.